Stockreport
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? [Yahoo! Finance]
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
McMillan's extensive leadership experience includes serving as Chief Financial Officer (“CFO”) and Vice President, Finance at Medtronic 's MDT Minimally Invasive Therapies Group. He also held several key positions at Covidien plc before Medtronic acquired it in 2015. Additionally, McMillan held CFO positions in leading healthcare companies like Solventum Corporation (a 3M Company carve-out) and Insulet. With the latest addition, Hologic's current board stands to benefit from McMillan's wealth of financial expertise and profound understanding of the MedTech industry. The market sentiment also remained positive after the announcement, as the company's shares saw a 2.6% rise during the April 4 after-hours session. Over the past month, HOLX stock has declined 7.2%, narrower than the industry's 10.3% plunge and the broader Medical Market's 9.2% slide. The S&P 500 composite has dropped 9.7% in value in the same time frame. In comparison to its industry peers, the company has stood more
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | HOLX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
HOLX alerts
HOLX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
NEWS
NEWS
- New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration[Business Wire]
- Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance][Yahoo! Finance]
- New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA[Business Wire]
- $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOLX, MOFG, NIC, and AWK[PR Newswire]
- Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas Exane from an "outperform" rating to a "neutral" rating. They now have a $79.00 price target on the stock.[MarketBeat]
- More
HOLX
SEC Filings
SEC Filings
- 12/12/25 - Form PREM14A
- 11/18/25 - Form 4
- 11/18/25 - Form 4
- HOLX's page on the SEC website
- More